Last Call for Funding! 🚨 @LobularBCA is collaborating with Conquer Cancer’s EveryGrant to implement Clinical Research Grant program to fund independent physician investigators/research scientists who are committed to conducting preclinical, translational, or clinical ILC research. Apply soon: bit.ly/3OTflEW

LBCA is very excited to offer these important new ILC research grants!

🚨 Exciting news! 🚨 #SABCS24 is almost here, and I'm thrilled to share that 50 #ILC #Lobular abstracts will be presented this year! 📚✨ This is a major milestone—just a few years ago, we barely saw single-digit numbers. The progress is incredible! Huge kudos to @LobularBCA, @elbcc, @LobularBCUK, and @LobularIreland for championing this progress! 👏👏👏 @SABCSSanAntonio @AACR @OncoAlert @oncodaily

The Lobular Carcinoma Imaging Research Fellowship grant aims to fund a research project focused on advancing Invasive Lobular Carcinoma Imaging and cultivating new lobular breast disease treatments to improve patient outcomes. Apply here! snmmi.secure-platform.com/si…

October is #BreastCancerAwarenessMonth, and yesterday, October 15, was the first ever #LobularBreastCancerAwarenessDay. I was proud to support the efforts of Laurie Hutcheson and @LobularBCA by speaking at @DFCI_BreastOnc among an incredibly impressive lineup... 🧵

Mason Mitchell-Daniels, COO, @LobularBCA, Dr. Christine Brezden-Masley, @SinaiHealth, and Dr. David Lim, @WCHospital, joined Brenda Cunnington, Managing Director, Americas, @Trayport at @TMXGroup, to open the market to recognize the first ever Global Lobular Breast Cancer Awareness Day, on October 15th. Invasive lobular carcinoma (ILC), also known as lobular #breastcancer, comprises 15% of all breast cancer diagnoses. Despite this incidence, there has been a lack of attention paid to the disease and a lack of funding for scientific research. October is breast cancer awareness month worldwide; declaring October 15th Global Lobular Breast Cancer Awareness Day – will help raise worldwide awareness of this breast cancer type. Many scientific studies have confirmed that lobular breast cancer is a distinct breast cancer type and that it behaves differently from the more common non-lobular breast cancers. But, for decades, in part because of the smaller numbers of patients at any one site and the insufficient standardization of the diagnosis for pathologists and radiologists, there has been a paucity of research. Therefore, though quite different, #lobularcancer is treated the same as other non-lobular tumors.

Today is the inaugural Global Lobular #BreastCancerAwareness Day! Help spread the word that #LobularBreastCancer may not always be a lump and can be missed on a mammogram. Learn more here: lobularbreastcancer.org/octo… #BreastCancer #learnaboutlobular #missedonmammogram

Thrilled to host @LobularBCA at @MSKCancerCenter for our Lobular breast cancer town hall and to commemorate October 15th as Lobular Breast Cancer Awareness day!

NEW Grant opens today! This grant aims to fund a research project focused on advancing Invasive Lobular Carcinoma Imaging and cultivating new lobular breast disease treatments to improve patient outcomes. Apply here! snmmi.secure-platform.com/si…

The LBCA Invasive Lobular Carcinoma Research Grant application deadline is extended to Sept. 23rd, details here: society.asco.org/career-deve…

LBCA’s latest 5-minute PSA addresses why breast cancer clinical trials are so crucial for finding treatments for all breast cancer types. Watch and share: lobularbreastcancer.org/lbca… #breastcancerresearch #breastcancerclinicaltrials #breastcancertreatments #breastcancerpsa

The new $5K sponsorship - the Lobular Breast Cancer Research Abstract Merit Award is announced in collaboration with @aacr_cancerresearch for the best abstracts on lobular breast cancer at SABCS. Read more here: lobularbreastcancer.org/anno… #lobularbreastcancer #ilcresearch

LBCA is announcing another ILC grant solicitation for two ILC research grants of $50K each in partnership with the American Society for Clinical Oncology (ASCO) and two generous partners. More info here: society.asco.org/career-deve… read the RFP here: society.asco.org/sites/new-w…

We are thrilled to see this interview with LBCA Scientific Advisory Board Chair @JAMouabbi discussing #lobular #breastcancer at #SABCS23. Thanks, @SABCSSanAntonio, for sharing more about ILC with your audience. #bcsm

Dr. Jason Mouabbi discusses the challenges of treating lobular breast cancer with Dr. Kate Lathrop in this episode of SABCS Snippets, highlighting advances being presented at #SABCS23 to address these challenges. Watch now: youtu.be/5oW5JFQKipQ @JAMouabbi @AACR @UTHealthSAMDA

Come visit the Lobular Breast Cancer Alliance at #1615 #sabcs23 #bcsm #lobular #lobmob 🦞🦞🦞🦞

Are you at #SABCS23 this week? Be sure to stop by our booth (1615), meet us, and pick up some information to share about #lobular #breastcancer. @lbhutcheson @jackel626 @amymccart @SABCSSanAntonio #bcsm @double_whammied

Such a huge deal to see #lobular #breastcancer being added to the #SABCS23 lineup! #lobmob @lobularBCA @LobularBCUK @elbcc

Grateful for the opportunity to present at #SABCS23! Huge thanks to the organizing committee for the invitation. I’m optimistic about the future of ILC management and hope my presentation conveyed the promise ahead. 🙏 #EndCancer @MDAndersonNews @LobularBCA @OncoAlert @OncBrothers @SABCSSanAntonio @AACR @UTHealthSAMDA @VKaklamani @CarlosArteagaMD

The Lobular Breast Cancer Session today at #SABCS23 moderated by Dr Steffi Oesterreich @oesterreichs with Dr Jason Mouabbi @JAMouabbi Dr Christine Desmedt @ChristineDesme2 Dr Tari King @TariKingMD and Siobhán Freeney @BreastDense @LobularIreland @elbcc